Laboratory Corp of America (LH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 3,056,800 | 3,033,700 | 3,037,800 | 2,174,500 | 2,866,800 |
| Cost of Goods | 2,205,600 | 2,191,500 | 2,187,700 | 1,527,200 | 1,980,600 |
| Gross Profit | 851,200 | 842,200 | 850,100 | 647,300 | 886,200 |
| Operating Expenses | 599,500 | 576,400 | 521,000 | 701,699 | 512,800 |
| Operating Income | 252,300 | 266,300 | 329,800 | -54,200 | 374,000 |
| Interest Expense | 50,300 | 49,800 | 50,700 | 49,000 | 46,300 |
| Other Income | 36,700 | -11,500 | -6,800 | 24,900 | -12,200 |
| Pre-tax Income | 238,700 | 205,000 | 272,300 | -78,300 | 315,500 |
| Income Tax | 55,100 | 49,800 | 63,900 | -44,400 | 38,200 |
| Net Income Continuous | 183,600 | 155,200 | 208,400 | -33,900 | 277,300 |
| Net Income Discontinuous | N/A | 33,900 | 4,900 | 110,300 | 75,900 |
| Minority Interests | 300 | 200 | 400 | 300 | 400 |
| Net Income | $183,300 | $188,900 | $212,900 | $76,100 | $352,800 |
| EPS Basic Total Ops | 2.12 | 2.13 | 2.41 | 0.98 | 3.91 |
| EPS Basic Continuous Ops | 2.12 | 1.75 | 2.35 | -0.25 | 3.07 |
| EPS Basic Discontinuous Ops | N/A | 0.38 | 0.06 | 1.22 | 0.84 |
| EPS Diluted Total Ops | 2.11 | 2.12 | 2.39 | 0.97 | 3.90 |
| EPS Diluted Continuous Ops | 2.11 | 1.74 | 2.34 | -0.25 | 3.06 |
| EPS Diluted Discontinuous Ops | N/A | 0.38 | 0.05 | 1.21 | 0.84 |
| EBITDA(a) | $413,400 | $409,200 | $471,900 | $76,201 | $506,900 |